egyptian association of vascular biology and...
TRANSCRIPT
1
Egyptian Association of Vascular
biology and Atherosclerosis
شرايين القلب صلبالجمعية المصرية لت
CardioRisk 2015
Movenpick Hurghada,
Egypt
25-28 November 2015
Endorsed by:
International Atherosclerosis
Society
The European Atherosclerosis
Society
2
Dear Colleagues
On behalf of the Egyptian Association of Vascular biology &
Atherosclerosis (EAVA) and Cardio Risk scientific board,
Let me welcome you all in Cardio Risk 2015 that will be held in
Hurghada Egypt 25-28 November 2015.
The meeting this year will not only cover lipidology science but,
in addition, will extend to cover many subjects related to CV risk
factors especially hypertension and DM with eminent faculty.
Looking forward to seeing you all let me wish you an enjoyable
and fruitful meeting.
Ashraf Reda, MD, FESC
President of EAVA
Welcome Address
3
CardioRisk CME activities started 2011, with a series of accredited
educational meetings all over Egypt discussing assessment and management
of cardiovascular risk in view of the different national and international
guidelines.
The annual meeting this year, CardioRisk 2015, which will be held 26-28
November in Hurghada, Egypt, will celebrate the foundation of the
Egyptian Association of Vascular biology and Atherosclerosis (EAVA).
In addition to the cyclic CME activities, the annual congress and the
ongoing Egyptian risk factor and lipid project, EAVA is initiating the
CardioRisk research project including a national observational study and a
promoting program supporting researches addressing cardiovascular risk
and preventive strategies in the community.
CardioRisk 2015 scientific program will cover the recent updates in
atherosclerosis, vascular biology and cardiovascular prevention by eminent
speakers.
CardioRisk scientific committee has the pleasure to invite you to
participate and share with us the science of CardioRisk 2015 as well as the
beauty of Hurghada, Egypt.
About EAVA & CardioRisk
4
Cardio Risk Scientific Board
Prof. Ashraf Reda Professor of Cardiology Menoufia University
Prof. Atef Elbahry Professor of Cardiology
Port Said
Prof. Ihab Attia Professor of Cardiology Ain Shams University
Prof. Ossama Sanad Professor of Cardiology
Banha University
Executive board of the Egyptian Association of
Vascular biology and Atherosclerosis
Prof. Ashraf Reda Professor of Cardiology
Menoufia University
Prof. Atef Elbahry Professor of Cardiology
Port Said
Prof. Ihab Attia Professor of Cardiology
Ain Shams University
Prof. Ossama Sanad Professor of Cardiology
Banha University
Prof. Hany Ragy Professor of Cardiology
Cairo University
Prof. Sameh Salama Professor of Cardiology
Cairo University
Cardio Risk Board
5
Ahmed Elkersh Hosam Elaraby
Alaa Etman Hossam Mansour
Ali Abdel Rehim Ihab Attia
Amr Elhadidy Magdy Abdelhamid
Amr Kamal Mohamed Abdel Ghany
Ashraf Reda Mohamed Moharam
Atef Elbahry Mohamed Seteha
Awny Shalaby Mourad Beshay
Ayman Abo El Magd Nabil Farag
El Sayed Farag Nerin Okasha
Gamal Shaban Ossama Sanad
Hamza Kabil Sameh Salama
Hany Ragy Tamer Moustafa
Helmy Elghawaby Tarek El Kholy
Hesham Aboelenane Walid Abdo
EAVA CardioRisk Nucleous Board
6
Abdel-Moneim Ibrahim Cairo
Abdel-Rahman Sharaf Al Azhar
Abdulla Shehab UAE
Adel Allam Cairo
Adel El Etriby Ain Shams
Ahmed El Ghalid Suez Canal
Ahmed El Kersh Menoufia
Ahmed Khashaba Ain Shams
Ahmed Rozza Al Azhar
Ahmed Shawky Ain SHams
Ahmed Zaghloul Tanta
Alaa Etman NHI
Alaa Medhat Cairo
Ali Abdel Rehim Alexandria
Aly Orabi Al Azhar
Amin Fouad Shaker Cairo
Amr El Guindy Military Academy
Amr El Hadidy Cairo
Amr Kamal Alexandria
Amr Youssif Assiut
Amr Zaki Alexandria
Ashraf Ahmed NHI
Ashraf Reda Menoufiya
Atef Elbahry Port Said
Awny Gamal Menoufia
Faculty Guests
In Alphabetic Order
7
Ayman Abou El Magd Al Azhar
Ayman El Saeed Tanta
Bassem Zarif NHI
Fahmy Charl Alexandria
Ekram Sadek Tanta
El Sayed Abdel Khalik Banha
El Sayed Farag Zagazig
Feisal Radwan Mansoura
Gamal Shaaban NHI
Gamila Nasr Suiz Canal
Ghada Kazamel NHI
Hamza Kabil Banha
Hany Abdel Razek NHI
Hassan Khaled Cairo
Helmy El Ghawaby Cairo
Hesham Abou El Enein Banha
Hossam El Araby Assiut
Hossam El Shaer Zagazig
Hossam Mansour Six October
Ihab Attia Ain Shams
Islam Shawky Al Azhar
Khaled El Rabat Banha
Khaled Shokry Military Academy
Magdy Abdel Hamid Cairo
Magdy Abdel Samiea Zagazig
Magdy El Khadem NHI
Magdy Mattar Alexandria
Mahmoud El Badry Cairo
Mahmoud Hassanien Alexandria
Mahmoud Soliman Menoufia
8
Mohamed Abdel Ghany Cairo
Mohamed Gamal Assiut
Mohamed Sobhy Alexandria
Mostafa El Sayed Al Azhar
Mourad Beshay Menoufia
Nabil Farag Ain Shams
Nerin Okasha Ain Shams
Nevine Samy Menoufia
Ossama Sanad Banha
Ragab Abdel Salam Zagazig
Ramzy El Mawardy Ain Shams
Saed Shalaby Menoufia
Saif Kamal Cairo
Sameh Emil Military Academy
Sameh Salama Cairo
Samir Rafla Alexandria
Sanaa Abdel Shafi Cairo
Sherif El Beltagy Alexandria
Tamer Moustafa Zagazig
Tarek El Khouly Cairo
Tarek Naguib Zagazig
Wahid Radwan Cairo
Walid Abdo Menoufia
Yasser Abdel Hady Bani Suef
Yasser Huzayen Ain Shams
9
European Atherosclerosis Society
(EAS) was founded in 1964 with the aim of “advancing and
exchanging knowledge concerning the causes, natural history,
treatment and prevention of atherosclerotic disease”.
International Atherosclerosis Society
(IAS), incorporated in 1979, promotes, at an international
level, the advancement of science, research and teaching in the
field of atherosclerosis and related diseases.
Endorsements
10
The Accreditation Review Committee (ARC) of the American Association
of Continuing Medical Education (AACME) designates this medical
education activity for a maximum of 22.50 hours in the Category 1 credit of
the AACME Designation.
Conference Venue MÖVENPICK HURGHADA is located, nestled in Hurghada Bay, directly on its own beach and with private access to the Red Sea. Only a ten-minute drive from Hurghada International Airport and a few minutes from the city center. The Mövenpick Hurghada is nestled in Hurghada Bay, at the Southern end of town, directly on the famous promenade, a pedestrian road, locally known as “the Mamsha”.
Registration hours Registration desk will be ready on Wednesday 25th of November at 16:30
Registration desk will be ready on Thursday, 26th of November at 15:30
Registration desk will be ready on Friday, 27th of November at 15:00
General Information
Accreditation
11
Language The official language is English.
All lectures and presentations will be held in the English language only.
There will be no translation available
Housing All rooms are on half Board Basis.
Light Lunch is only served upon coupons.
Badge
All registrants and exhibitors must wear their name badge to have access to conference sessions, lunches. No exceptions will be made
Barcode Barcode will be printed on all badges of participants.
All access to Halls of the conference will be with the badge.
Barcode System will allow the calculation of participated hours in each
session for each candidate.
Weather
Wednesday 25th Thursday 26th
Friday
27th
Saturday
28th
Max 27 26 25 23
Min 16 13 13 14
Electricity The electricity supply in Egypt is 220 Volts, 50 Hz.
Most hotels also provide 110 Volts outlets for shavers
12
Coffee Break Wednesday 25th November 19:00-19:30
Lunch Wednesday 25th November 16:00-17:00
Thursday 26th November 15:30-16:00
Friday 27th November 15:00-15:30
Dinner times Dinner will be served daily at the main restaurant in the hotel according to
your accommodated.
Buses Menoufia
11:00 A.M Hilton Resort Alexandria
Cairo
14
Cardio Risk 2015
Expresses great gratitude to the following companies sharing
in the activities and success of the conference
Acknowledgments
17
Session 1 17:00 – 19:00
Lipidology Debates Chairperson (in alphabetical order)
Alaa Etman Mourad Beshay El Sayed Farag Sameh Salama
17:00 – 17:25 What should I do if I am concerned with statin
intolerance
Atef Elbahry Port Said
17:25 – 17:40 Discussion
17:40 – 18:05 Do patient’s goals and targets are still important for
LDL-C?
Ihab Attia Ain Shams
18:05 – 18:20 Discussion
18:20 – 18:45 Statin linked to raise risk of type 2 DM -----What
should I do?
Ashraf Reda Menoufia
18:45 – 19:00 Discussion
Coffee Break 19:00 – 19:30
Wednesday 25 November 2015 Main Hall
18
Session 1I 19:30 – 21:30
Diabetes Debate Chairperson (in alphabetical order)
Atef Elbahry Ihab Attia
Nevine Samy
19:30 – 19:55 Guidelines for BP control in DM: how can I
treat the diabetic hypertensive patients?
El Sayed Farag Zagazig
19:55 – 20:10 Discussion
20:10 – 20:35 The link between Diabetes and Atherosclerosis
Sameh Salama Cairo
20:35 – 20:50 Discussion
20:50 – 21:15 DPP4 Inhibitors and heart failure: should I be
concerned
Hossam El Araby Assiut
21:15 – 21:30 Discussion
Wednesday 25 November 2015 Main Hall
19
Session III 21:35 – 22:05
Hypertension Guidelines
Chairperson (in alphabetical order) Ahmed El Kersh Awny Gamal
Alaa Etman Ihab Attia
21:35 -21:55 Hypertension guidelines and the role of
combination therapy
Walid Abdo Menoufia
21:55 – 22:05 Discussion
Wednesday 25 November 2015 Main Hall
21
Session IV 16:00 – 17:00
Vascular Biology and Sent Technology
Chairperson (in alphabetical order) Amr El Hadidy Ossama Sanad
Ghada Kazamel Tarek Naguib
Magdy Mattar
16:00 – 16:15 Atherosclerosis, angiogenesis and plaque rupture
Abdelmonem Ibrahim Cairo
16:15 – 16:20 Discussion
16:20 – 16:35
New technology in drug release:3rd generation
DES
Sameh Salama Cairo
16:35 – 16:40 Discussion
16:40 – 16:55 Biodegradable polymer and Vascular endothelium
Hossam Mansour Six October 16:55 – 17:00 Discussion
Thursday 26 November 2015 Main Hall
22
Session V 17:05 – 18:20
Management of Difficult to Treat Patients Chairperson (in alphabetical order)
Gamal Shaaban Sameh Emil
Khalid El Rabat Samir Rafla
Hamza Kabil
17:05 – 17:20 Molecular basis for statin myopathy
Atef Elbahry Port Said
17:20 – 17:25 Discussion
17:25 – 17:35
Approaches to the management of patients with
resistant hypertension Ashraf Reda Menoufia
17:35– 17:40 Discussion
17:40 – 17:55 Value of ABPM in day to day practice
Magdy Abdel Hamid Cairo 17:55 – 18:00 Discussion
18:00 – 18:15 Combination therapy and BP control
Nabil Farag Ain Shams 18:15 – 18:20 Discussion
Thursday 26 November 2015 Main Hall
23
Session VIII 18:25 – 18:55
Optimizing Heart Failure Management
Chairperson (in alphabetical order) Ahmed Zaghloul Mohamed Sobhy
Ekram Sadek Ramez Guindy
Hany Abdel razek Yasser Huzayen
18:25 – 18:45
Taking the best chances to optimize the heart
failure management
Adel El Etriby Ain Shams
18:45 – 18:55 Discussion
Thursday 26 November 2015 Main Hall
24
Session IX 19:00 – 20:00
Quad of the trials I Chairperson (in alphabetical order)
Ahmed El Ghalid Mohamed Selim
Gamila Nasr Mostafa El Sayed
Hesham Abou EL Enin Yasser Abdel Hady
19:00 – 19:12 IMPROVE IT trial
Ashraf Reda Menoufiya 19:12 – 19:15 Discussion
19:15 – 19:27 TECOS trial
Ali Abdel Rehim Alexandria 19:27– 19:30 Discussion
19:30– 19:42 PARADIGM HF
Ihab Attia Ain Shams 19:42 – 19:45 Discussion
19:45 – 19:57 PEGASUS
Amr Kamal Alexandria 19:57 – 20:00 Discussion
Thursday 26 November 2015 Main Hall
25
Session X 20:05 – 20:40
CV Risk Reduction Chairperson (in alphabetical order)
Adel El Etriby Ihab Attia
Ezz El Sawy Mohamed Sobhy
Mahmoud El Badry Seif Kamal
Hany Abdel Razek
20:05 - 20:20
Evidence of Dyslipidemia management in 2ry
prevention of IHD
Nabil Farag Ain Shams
20:20 – 20:35 BPV Evidence in management of HTN
Magdy Abdel Hamid Cairo
20:35 - 20:40 Discussion
Thursday 26 November 2015 Main Hall
26
Session XI 20:45 – 21:25
VK antagonist oral anticoagulants Chairperson (in alphabetical order)
Ahmed Metawea Ashraf Reda
Aly Orabi Hala Mahfouz
Amr El Guindy Mohamed Sobhy
20:45 – 21:00 Making Sense of the New Hypertensive
Guidelines
Amin Fouad Shaker Cairo
21:00 – 21:05 Discussion
21:05 – 21:20 Stroke Prevention in Non Valvular AF:
Where are we today?
Atef Elbahry Port Said
21:20 – 21:25 Discussion
Thursday 26 November 2015 Main Hall
27
Session XII 21:30 – 22:30
Imaging and Atherosclerosis Chairperson (in alphabetical order)
Abdel Rahman Sharaf Gamal El Shaer
Ahmed Shafie Ammar Tarek El Khouly
Ayman El Saeed
21:30 – 21:50 Value of CT calcium scoring
Islam Shawky Al Azhar
21:50 – 22:00 Discussion
22:00 – 22:20 CT calcium scoring beyond the coronaries
Adel Allam Al Azhar
22:20 – 22:30 Discussion
Thursday 26 November 2015 Main Hall
29
Session XIII 15:30 – 16:30
Novel Approaches in the Diabetes Management Chairperson (in alphabetical order)
Ali Abdel Rehim Saeed Shalaby
El Sayed Abdel Khalik Feisal Radwan
Mahmoud Soliman
15:30 – 15:45 Diabetic treatment and the risk of heart failure
Mahmoud Hassanien Alexandria
15:45 – 15:50 Discussion
15:50 – 16:05 BP control in the diabetics
Alaa Etman NHI 16:05 – 16:10 Discussion
16:10 – 16:25 Lipid management in the diabetics
Mohamed Abdel Ghany Cairo
16:25 – 16:30 Discussion
Friday 27 November 2015 Main Hall
30
Session XIV 16:35 – 17:35
PCSK9 inhibitors and future of dyslipidemia management
Chairperson (in alphabetical order) Ashraf Reda Fayez Faeik
Ramzy El Mawardy Sanaa Abdel Shafei
Sameh Salama
16:35 – 16:50 Molecular basis for statin myopathy
Atef Elbahry Port Said
16:50 – 16:55 Discussion
16:55 – 17:10 Genetic variation of PCSK9
Ahmed Shawky Ain shams
17:10 – 17:15 Discussion
17:15 – 17:30 PCSK 9 inhibitors: which patient
Mohamed Abdel Ghany Cairo
17:30 - 17:35 Discussion
Friday 27 November 2015 Main Hall
31
Session XV 17:40 – 18:30
Coronary Intervention in the Real World Chairperson (in alphabetical order)
Alaa Medhat Ayman Aboul Magd
Amr Zaki Nerin Okasha
17:40 – 18:00 The Diabetic patient & PCI
Ahmed Khasaba Ain Shams
18:00 – 18:05 Discussion
18:05 – 18:25 3rd Generation DES in Different Anatomies
Ashraf Ahmed NHI
18:25 – 18:30 Discussion
Friday 27 November 2015 Main Hall
32
Session XVI 18:35 – 19:05
Combination Therapy in Dyslipidemia Management
Chairperson (in alphabetical order)
Atef Elbahry Bassem Zarif
Amr Youssef Ihab Attia
Ashraf Reda Ossama Sanad
18:35-18:55 The Lower The Better Concept
Mohamed Abdel Ghany Cairo
18:55-19:05 Discussion
Friday 27 November 2015 Main Hall
33
Session XVII 19:10 – 20:10
Reducing the Cardiovascular Risk Chairperson (in alphabetical order)
Atef Elbahry Magdy El Khadem
Hassan Khaled Ossama Sanad
Ihab Attia Tamer Moustafa
19:10-19:30 Hypertension, Diabetes and Nephropathy:
What to Do
Nabil Farag Ain Shams
19:30-19:40 Discussion
19:40-20:00
The dilemma of dual antiplatelet therapy between
duration and combination
Ashraf Reda Menoufia
20:00-20:10 Discussion
Friday 27 November 2015 Main Hall
34
Session XVIII 20:15 – 21:15
Quad of the trials II Chairperson (in alphabetical order)
Fahmy Charl Mohamed Gamal
Khaled Shokry Ragab Abdel Salam
Magdy Abdel Samiea Wahid Radwan
20:15 - 20:27 PLANET 1 and PLANET 2
Helmy El Ghawaby Cairo
20:27 - 20:30 Discussion
20:30 - 20:42 CEPHEUS
Abdullah Shehab UAE
20:42 - 20:45 Discussion
20:45 - 20:57 CVLPRIT trail Ayman Abou El Magd Al Azhar
20:57 - 21:00 Discussion
Friday 27 November 2015 Main Hall
35
Session XIX 21:20 – 22:00
Reducing The Cardio Vascular burden
Chairperson (in alphabetical order)
Ahmed Rozza Ossama Sanad
Naglaa Fahim
21:20 - 21:35 Role of Atacand in the journey of HTN to HF Ihab Attia Ain Shams
21:35 - 21:50 Role of Atacand in the journey of HTN to HF Atef Elbahry Port Said
21:50 - 22:00 Discussion
Friday 27 November 2015 Main Hall